Registrations have closed.
2nd Gene Therapy for Ophthalmic Disorders
by
145 145 people viewed this event.
Overcoming the industry’s translational challenges in targeting both rare and common ophthalmic disorders including wet AMD, dry AMD, DME, IRDs and more. Time: 8:00 am – 5:00 pm
Additional Details
Etkinlik Ülkesi - Other
